Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis

NCT05571228 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT05571228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05571228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis
Lead sponsor
Queen's University
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2020
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, schizophrenia